Illuminating drug discovery with biological pathways

被引:82
|
作者
Apic, G
Ignjatovic, T
Boyer, S
Russell, RB
机构
[1] Cambridge Cell Networks, Cambridge CB3 0FD, England
[2] AstraZeneca R&D, Safety Assessment, S-43183 Molndal, Sweden
[3] EMBL, D-69112 Heidelberg, Germany
关键词
systems biology; drug discovery; biological pathways;
D O I
10.1016/j.febslet.2005.02.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Systems biology promises to impact significantly on the drug discovery process. One of its ultimate goals is to provide an understanding of the complete set of molecular mechanisms describing an organism. Although this goal is a long way off, many useful insights can already come from currently available information and technology. One of the biggest challenges in drug discovery today is the high attrition rate: many promising candidates prove ineffective or toxic owing to a poor understanding of the molecular mechanisms of biological systems they target. A "systems" approach can help identify pathways related to a disease and can suggest secondary effects of drugs that might cause these problems and thus ultimately improve the drug discovery pipeline. (c) 2005 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1872 / 1877
页数:6
相关论文
共 50 条
  • [31] Screening for transient biological interactions as applied to albumin ligands: A new concept for drug discovery
    Ohlson, Sten
    Shoravi, Siamak
    Fex, Tomas
    Isaksson, Roland
    ANALYTICAL BIOCHEMISTRY, 2006, 359 (01) : 120 - 123
  • [32] NMR in drug discovery: A practical guide to identification and validation of ligands interacting with biological macromolecules
    Gossert, Alvar D.
    Jahnke, Wolfgang
    PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 2016, 97 : 82 - 125
  • [33] Potential biological targets for bioassay development in drug discovery of Sturge-Weber syndrome
    Mohammadipanah, Fatemeh
    Salimi, Fatemeh
    CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 91 (02) : 359 - 369
  • [34] Biological Scaffolds in 3D Cell Models: Driving Innovation in Drug Discovery
    Dave, Raj
    Pandey, Kshipra
    Patel, Ritu
    Gour, Nidhi
    Bhatia, Dhiraj
    STEM CELL REVIEWS AND REPORTS, 2025, 21 (01) : 147 - 166
  • [35] Microfluidic Devices for Automation of Assays on Drosophila Melanogaster for Applications in Drug Discovery and Biological Studies
    Ghaemi, Reza
    Selvaganapathy, Ponnambalam R.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2016, 17 (09) : 822 - 836
  • [36] Stem cell signaling as a target for novel drug discovery: recent progress in the WNT and Hedgehog pathways
    An, Songzhu Michael
    Ding, Qiang Peter
    Li, Ling-song
    ACTA PHARMACOLOGICA SINICA, 2013, 34 (06) : 777 - 783
  • [37] Capturing a Comprehensive Picture of Biological Events From Adverse Outcome Pathways in the Drug Exposome
    Wu, Qier
    Bagdad, Youcef
    Taboureau, Olivier
    Audouze, Karine
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [38] Stem cell signaling as a target for novel drug discovery: recent progress in the WNT and Hedgehog pathways
    Songzhu Michael An
    Qiang Peter Ding
    Ling-song Li
    Acta Pharmacologica Sinica, 2013, 34 : 777 - 783
  • [39] Application of Metabolomics in Drug Discovery, Development and Theranostics
    Cuperlovic-Culf, Miroslava
    Culf, Adrian S.
    Morin, Pier Jr
    Touaibia, Mohamed
    CURRENT METABOLOMICS, 2013, 1 (01) : 41 - 57
  • [40] Natural Products in Drug Discovery: Approaches and Development
    Tresina, Pious Sons
    Selvam, Murugeswaran Santhiya
    Rajesh, Authinarayanan
    Doss, Asirvatham
    Mohan, Veerabahu Ramasamy
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (35A) : 93 - 110